NEXTURNBIOSCIENCE Co., LTD Logo

NEXTURNBIOSCIENCE Co., LTD

089140 | KO

Overview

Corporate Details

ISIN(s):
KR7089140008
LEI:
Country:
South Korea
Address:
경기도 용인시 기흥구 기흥단지로121번길 35 (고매동), 용인시
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-26 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 9.5 KB
2025-08-25 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 107.5 KB
2025-08-25 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 69.6 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.5 MB
2025-08-07 00:00
Share Issue/Capital Change
전환가액의조정
Korean 10.1 KB
2025-08-07 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 9.5 KB
2025-08-01 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 86.1 KB
2025-07-30 00:00
Share Issue/Capital Change
전환청구권행사
Korean 9.1 KB
2025-07-28 00:00
Share Issue/Capital Change
전환가액의조정
Korean 10.7 KB
2025-07-16 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(자기전환사채매도결정)
Korean 62.7 KB
2025-07-16 00:00
M&A Activity
주요사항보고서(회사합병결정)
Korean 95.5 KB
2025-07-16 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 6.0 KB
2025-07-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-07-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.7 KB
2025-07-03 00:00
M&A Activity
합병등종료보고서(합병)
Korean 21.8 KB

Automate Your Workflow. Get a real-time feed of all NEXTURNBIOSCIENCE Co., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NEXTURNBIOSCIENCE Co., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NEXTURNBIOSCIENCE Co., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ProQR Therapeutics N.V. Logo
Biotech developing RNA-editing therapies for genetic disorders using the body's own enzymes.
United States of America
PRQR
Prostatype Genomics AB Logo
Provides a genetic test to assess prostate cancer aggressiveness and guide treatment choices.
Sweden
PROGEN
Protagenic Therapeutics, Inc.\new Logo
Developing novel peptide drugs to treat stress-related neuropsychiatric & CNS disorders.
United States of America
PTIX
Protara Therapeutics, Inc. Logo
Clinical-stage biotech developing cell therapies for cancer and rare diseases.
United States of America
TARA
PROTEINA CO.,LTD. Logo
A biotech firm specializing in proteomics for drug discovery and diagnostics in oncology.
South Korea
468530
PROTEOME SCIENCES PLC Logo
CRO providing proteomics services & TMT® tags to biopharma for drug discovery & biomarkers.
United Kingdom
PRM
PROTHENA CORP PUBLIC LTD CO Logo
Advancing antibody-based therapies for neurodegenerative and rare amyloid diseases.
United States of America
PRTA
PROVEXIS PLC Logo
Develops & licenses Fruitflow®, a patented ingredient for heart health in food & supplements.
United Kingdom
PXS
Psomagen, Inc. Logo
A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.
United States of America
950200
Psych Capital Plc Logo
A life sciences firm developing psilocybin treatments for anorexia and mental health conditions.
United Kingdom
PSY

Talk to a Data Expert

Have a question? We'll get back to you promptly.